Optimum Strategic Communications
In partnership with

12th Annual Healthcare Investor Conference

8th October 2020

Discover the EventConference Booklet


The coronavirus pandemic has impacted us all and in ways that were impossible to predict just a few months ago. Across the healthcare sector we are seeing an unprecedented response in communication, collaboration, speed and agility, as we unite in a common purpose to fight the COVID-19 pandemic.

No-one is clear when we will come out of the other side and what will be the longer-term impact on how we work and do business. And of course, the key question is how it will impact investments in the biotech & medtech sector .

The Optimum Strategic Communications Annual Healthcare Investor Conference in partnership with Dechert LLP will take place on Thursday 8th October 2020.

The conference now in its 12th year, features leading speakers from the healthcare and investment communities each providing insights on the latest trends, developments and impacts on the industry.

The audience consists of senior management from private and public companies across Europe’s healthcare and life-sciences sector, as well as a number of investors and analysts from the investment community.

For more information please follow the link to the Press release .


Reviews from our past speakers on what makes Optimum's Healthcare Investor Conference unique.


Leading speakers from the healthcare and investment communities providing insights on the latest trends and impacts on the industry.

Past Speakers

A selection of some of our brilliant panellists from previous years.

  • Kasim Kutay Kasim Kutay Novo Holdings
  • Werner Lanthaler Werner Lanthaler Evotec
  • Anne Marden Anne Marden JP Morgan Asset Management
  • Jan van de Winkel Jan van de Winkel Genmab
  • Geraldine O'Keeffe Geraldine O'Keeffe LSP
  • Kieran Murphy Kieran Murphy GE Healthcare
  • Antoine Papiernik Antoine Papiernik Sofinnova Partners
  • Clive Cookson Clive Cookson Financial Times
  • Oliver Maier Oliver Maier Bayer
  • Person Name Dan Mahony Polar Capital
  • Martin Murphy Martin Murphy Syncona
  • Linden Thomson Linden Thomson AXA Investment Managers
  • Edwin Moses Edwin Moses NED Various
  • Annalisa Jenkins Annalisa Jenkins NED Various
  • Paul Major Paul Major Bellevue Asset Management
  • Person Name Professor Tony Young OBE NHS England
  • Person Name Roel Bulthuis INKEF Capital
  • David Pinniger David Pinniger Polar Capital
  • Vicky Darbyshire Vicky Darbyshire JP Morgan Asset Management
  • Hakan Goker Hakan Goker M Ventures
  • George Freeman George Freeman Government adviser on Life Sciences
  • Catherine Pickering Catherine Pickering iOnctura
  • Gavin MacGregor Gavin MacGregor HBM Partners
  • Mike Ward Mike Ward Informa Group
  • Andrew Holder Andrew Holder Mole Valley Asset Management
  • Richard Girling Richard Girling Centreview Partners
  • Justin Stebbing Justin Stebbing Imperial College London
  • Deborah Harland Deborah Harland SR One
  • Lisa Urquhart Lisa Urquhart Vantage
  • Thomas Burt Thomas Burt Sofinnova
  • Harry Destecroix Harry Destecroix Unit DX
  • Ilan Chaitowitz Ilan Chaitowitz Nomura Asset Management
  • Dale Raine Dale Raine Lazard
  • Jonathan Tobin Jonathan Tobin Arix Bioscience
  • Soren Moller Soren Moller Novo Holdings
  • Jasper Bos Jasper Bos M Ventures
  • Marc Booty Marc Booty Pictet Asset Management
  • Eva Haas Eva Haas Optimum Strategic Communications
  • Ian Nicholson Ian Nicholson F2G
  • Anker Lundemose Anker Lundemose Mission Therapeutics
  • Sam Fazeli Sam Fazeli Bloomberg Intelligence
  • Professor Sir Michael Rawlins Professor Sir Michael Rawlins NICE
  • Andy Richards CBE Andy Richards CBE NED Various
  • Mary Clark Mary Clark Optimum Strategic Communications


Optimum Strategic Communications in partnership with Dechert

Optimum Strategic Communications

Optimum Strategic Communications is an international strategic healthcare communications firm which specialises in investor relations, corporate and financial communications. Our senior team of healthcare specialists are experienced and trusted advisors to some of the world’s most exciting public and private companies, both large and small, across pharmaceuticals, medtech, biotech, health tech and healthcare services.

Over the last 20 years we have worked with over 200 healthcare companies, advising them on financial communications and investor relations, including major corporate activity such as fundraising, IPOs, and M&A, as well as corporate reputation and crisis scenarios. We have advised on numerous cross border transactions and have supported IPOs on the London Stock Exchange, Euronext and NASDAQ.

We have an exceptional network of contacts across the international investment community in Europe and the US; contacts we have built and maintained over the last two decades. Our team includes ex-fund managers and equity analysts, scientists and financial and corporate communications specialists. www.optimumcomms.com

Dechert’s Life Sciences and Healthcare group provides global support to Life Sciences and Healthcare industry participants and investors, assisting them to navigate the interplay of business, legal, and regulatory issues. For further information click here.


The half day event will kick off at 11:30 with fireside chats and panel discussions throughout the afternoon. We will finish with virtual networking until 7pm.

All times listed are in GMT.

When & Where

We look forward to welcoming you to our first virtual conference.

This year’s conference will be run as a virtual event. Joining instructions will be sent to confirmed attendees the week prior to the event.